Background: Increased plasma concentrations of free fatty acids (FFA) can lead to insulin resistance in skeletal muscle, impaired effects on mitochondrial function, including uncoupling of oxidative phosphorylation and decrease of endogenous antioxidant defenses. Nitric oxide (NO) is a highly diffusible gas that presents a half-life of 5-10 seconds and is involved in several physiological and pathological conditions. The effects of palmitic acid on nitric oxide (NO) production by rat skeletal muscle cells and the possible mechanism involved were investigated. Methods: Primary cultured rat skeletal muscle cells were treated with palmitic acid and NO production was assessed by nitrite measurement (Griess method) and 4,5-diaminofluorescein diacetate (DAF-2-DA) assay. Nuclear factor-kappa B (NF-κB) activation was evaluated by electrophoretic mobility shift assay and iNOS protein content by western blotting. Results: Palmitic acid treatment increased nitric oxide production. This effect was abolished by treatment with NOS inhibitors, L-nitro-arginine (LNA) and L-nitro-arginine methyl esther (L-NAME). NF-κB activation and iNOS content were increased due to palmitic acid treatment. The participation of superoxide on nitric oxide production was investigated by incubating the cells with DAF-2-DA in the presence or absence of palmitic acid, a superoxide generator system (X-XO), a mixture of NOS inhibitors and SOD-PEG (superoxide dismutase linked to polyethylene glycol). Palmitic acid and X-XO system increased NO production and this effect was abolished when cells were treated with NOS inhibitors and also with SOD-PEG. Conclusions: In summary, palmitic acid stimulates NO production in cultured skeletal muscle cells through production of superoxide, nuclear factor-kappa B activation and increase of iNOS protein content.
Introduction
The ability to maintain skeletal muscle contraction is mainly dependent upon oxidation of fatty acids and glucose. Carbohydrate is predominantly used during high intensity muscle contraction (glucose uptake can increase as much as 50-fold) [1] , whereas fatty acids are the predominant fuel during low to moderate intensity muscle contraction (for review see [2] ). These metabolic events are associated with increased production of reactive oxygen (ROS) and reactive nitrogen (RNS) species in skeletal muscle [3, 4] . Superoxide and nitric oxide are the two main reactive species produced (a ROS and a RNS, respectively).
Nitric oxide (NO) is a highly diffusible gas that presents a half-life of 5-10 seconds and is involved in several physiological and pathological conditions [5] . NO acts as modulator of skeletal muscle contraction, glucose transport in skeletal muscle and adipocytes, blood flow and force generation in skeletal muscle [6] [7] [8] . These effects occur partially through changes in gene expression and mitochondrial function [8, 9] .
NO is synthesized from L-arginine by nitric oxide synthase (NOS) using NADPH and oxygen as co-substrates [10] . Three isoforms of NO synthase have been described: neuronal (nNOS or NOS 1), inducible (iNOS or NOS 2) and endothelial (eNOS or NOS 3) [11] . In skeletal muscle cells, eNOS is localized in mitochondria and nNOS is associated with the dystrophin complex in the sarcolemma. iNOS is expressed at very low levels in skeletal muscle, however, under the effect of proinflammatory cytokines, such as tumor necrosis factor alpha (TNF-α) and interleukin-1beta (IL-1β) [12, 13] , iNOS expression can be markedly elevated. iNOS expression is regulated by PPAR (alpha and gamma) and the nuclear factor kappa B (NF-κB) [14, 15] .
Increased plasma concentrations of free fatty acids (FFA) lead to insulin resistance in skeletal muscle [16] . In addition, high intracellular concentrations of FFA have impairing effects on mitochondrial function, including uncoupling of oxidative phosphorylation and decrease of endogenous antioxidant defenses (e.g. reduction of intracellular gluthathione content) [17] . Palmitic acid is one of the most abundant fatty acid in plasma of human and rodents and represents 22-25% of the total fatty acids [18, 19] . We recently reported increased production of superoxide by palmitic acid oxidation in primary cultured rat skeletal muscle cells [20] . Rachek et al. [21] showed increased production of RNS by palmitic acid (0.5, 1 and 2 mM) in L6 rat skeletal muscle cells. In spite of this observation, the precise mechanisms by which FFA modulate NO generation still remain unknown.
The aim of the present study was to examine the effect of palmitic acid on nitric oxide production by rat skeletal muscle cells and the possible mechanism involved. The present work is the first to investigate the effect of palmitic acid on NO production by primary cultured rat skeletal muscle cells. This experimental protocol was used to avoid the interference of endothelial cells, an important generating site of NO that could mask the NO production by skeletal muscle, which may occur in whole skeletal muscle preparations (muscle incubation).
Materials and Methods
The experimental procedure of this study was approved by the Ethical Committee of the Institute of Biomedical Sciences, University of São Paulo (Protocol 137, page 24, book 2).
Primary culture of rat skeletal muscle cells
Primary culture of rat skeletal muscle cells was performed as previously described by others [22] and in our studies [20, 23] . Wistar rats weighing approximately 100 g were used in the experiments. Briefly, soleus, gastrocnemius, and quadriceps muscles were dissected, cut into small pieces and digested with 2% type II collagenase, 0.25% trypsin and 0.1% DNAse for isolation of myoblasts. Cells were placed into plates of 6 wells (250,000 cells per well) in DMEM (Dulbecco's Modified Eagle Medium) containing 1% penicillin, 10% fetal bovine serum and 10% horse serum. After 2-3 days of culture, myoblasts were differentiated into skeletal muscle cells in DMEM containing 10% horse serum for 4-5 days. Palmitic acid (Sigma, St. Louis, 
Determination of palmitic acid cytotoxicity
The cytotoxicity of palmitic acid was assessed by flow cytometry, as described in our previous study [24] , after treatment of cells for 3 h with this fatty acid at 25 µM. At the end of the culture period, trypsin was added to the medium and cell membrane integrity was then evaluated. Briefly, 50 µL of a propidium iodide (PI) solution (100 mg/mL in saline buffer) were added to the cells. After 5 min incubation at room temperature, the cells were examined in a FACScalibur flow cytometer (Becton Dickinson, CA, USA) by using the Cell Quest software. Fluorescence was measured using the FL2 channel (Orange-red fluorescence -585/42nm). Ten thousand cells were analyzed per experiment.
Effect of palmitic acid on nitric oxide production
The effect of palmitic acid on NO production by primary cultured rat skeletal muscle cells was examined by two methods: nitrite measurement [25] and with the use of the fluorescent compound 4,5-diaminofluorescein diacetate (DAF-2-DA) (Molecular Probes, Eugene, OR, USA) [26] . DAF-2 selectively traps NO between two amino groups yielding the fluorescence of triazolofluorescein [27] .
In the nitrite measurement method, cells were incubated at 37°C for one hour in the absence or presence of palmitic acid (25 µM). The samples were then immediately frozen and stored at -80°C for further analysis. Briefly, 100 µL of medium were incubated with an equal volume of Griess reagent (1% sulfanilamide/0.1% naphthylethylene diamine/2.5% H 3 P0 4 ) at room temperature for 10 min. After that, absorbance was measured at 550 nm. Nitrite was determined by using sodium nitrite as standard. Cell-free medium contained 0.2 to 0.3 nmol of nitrite per well. This concentration of nitrite was determined in each experiment and subtracted from the value obtained with cells.
For the measurement with DAF-2-DA, samples were treated for 30 min with the fluorescent compound (final concentration of 10 µM in Dulbecco's Phosphate Buffered Saline -DPBS -containing 5 mM glucose) and then incubated at 37°C for one hour in the presence or absence of palmitic acid (25 µM). After this period, cells were analyzed in a fluorescence microscope. The fluorescence intensity was quantified using the ImageJ 1.43 software (Wayne Rasband, NIH, USA, http://rsb.info.nih.gov/ij/).
Superoxide participation in the nitric oxide production
The influence of superoxide on NO production by primary cultured rat skeletal muscle cells was investigated by the addition of a superoxide generator system (xanthine oxidase (XO) and its substractxanthine (X)). Firstly, a control assay was performed to confirm the specificity of this generator system. Superoxide production, in the presence of this superoxide generator system, was evaluated by using the dihydroethidium (DHE) oxidation method [28] . The activity of xanthine oxidase (0.2 U/mL) and the concentration of xanthine (5 µM) were the same previously used by Flohe and Otting [29] . A control group without XO and another group with palmitic acid (25 µM) only were also included. Briefly, DHE at 1 µM (final concentration in DPBS containing 5 mM glucose) was added to the cells 30 min before the addition of palmitic acid or XO. One hour later, cells were analyzed in a fluorescence microscope. The fluorescence intensity was quantified as described above.
NO production was then evaluated using the fluorescent DAF-2-DA (Molecular Probes, Eugene, OR, USA) [26] , as previously described. For that, skeletal muscle cells were treated with XO or palmitic acid in the presence or absence of SOD-PEG (superoxide dismutase linked to polyethylene glycol), an antioxidant enzyme involved in the dismutation of superoxide, at 100 U/mL, or with a mixture of L-nitro-arginine (LNA) and L-nitro-arginine methyl ester (L-NAME) (NOS inhibitors) at 500 µM.
Determination of nNOS, eNOS and iNOS protein content
After one hour of incubation at 37°C in the absence or presence of palmitic acid (25 µM), skeletal muscle cells were homogenized in extraction buffer (100 mM Trizma, pH 7.5; 10 mM EDTA; 100 mM NaF; 10 mM sodium pyrophosphate; 10 mM sodium orthovanadate; 2 mM phenylmethanesulfonyl fluoride; 0.01 mg/mL aprotinin; at 4°C) for 30s. After homogenization, triton-X-100 was added at 1% and samples incubated for 30 min at 4°C. Samples were centrifuged at 13,000×g for 20 min at 4°C. Aliquots of supernatants (5 µL) were then used for the measurement of total protein content as described by Bradford [30] . Equal Cellular Physiology and Biochemistry amounts of proteins of each sample (75 µg) were submitted to electrophoresis and immunoblotting with the specific antibody as described by Towbin [31] . Briefly, proteins of the gel were transferred to a nitrocellulose membrane at 120 V for 1 h. Non-specific bounds were blocked by incubating the membranes with 5% defatted milk in basal solution (10 mM Trizma, pH 7.5; 150 mM NaCl; 0.05% Tween 20), at room temperature, for 2 h. Membranes were washed 3 times for 10 min each in basal solution and then incubated with specific antibodies for nNOS, eNOS and iNOS (1:1,000 dilution) in basal solution containing 3% defatted milk, at room temperature, for 3 h. Membranes were washed again (3 times for 10 min each) and incubated with anti-IgG antibody (1:10,000 dilution) linked to horseradish peroxidase in basal solution containing 1% defatted milk, at room temperature, for 1 h. Following the washings again, membranes were incubated with substrate for peroxidase and chemiluminescence enhancer (ECL Western Blotting System Kit, GE Health Care, Little Chalfont, Buckinghamshire, England) for 1 min and immediately exposed to X-ray film. Films were then revealed in the conventional manner. Band intensities were quantified by optical densitometry (ImageJ 1.43, Wayne Rasband, NIH, USA, http://rsb.info.nih.gov/ij/). The results were normalized to Ponceau S staining [32] .
To evaluate the possible participation of superoxide in the iNOS expression, the same experiment described above was performed in the presence of SOD-PEG (100 U/mL).
Electrophoretic mobility shift assay NF-κB activation was evaluated after treatment of the cells with 25 µM palmitic acid for 1h. Nuclear extract from skeletal muscle cells was obtained as previously described [33] . Double-stranded oligonucleotides containing the NF-κB (5′-AGTTGAGGGGACTTTCCCAGGC-3′) consensus binding site [34] were end-labeled using T4 PNK and [γ- . Competitive binding assays were conducted under the same conditions with the addition of 2 pmol (100-fold molar excess) unlabeled competitor oligonucleotides. The DNA-protein complexes were electrophoresed on 4% non-denaturing polyacrylamide gel, at 4°C, in 45 mM Tris, 45 mM borate and 1 mM EDTA buffer. The gels were dried and subjected to autoradiography. The blots were analyzed by scanner densitometry (Image Master 1D ® , Amersham Biosciences) and the results of binding activity were expressed as arbitrary units. In order to evaluate the possible participation of superoxide in this process, the same experiment described above was performed in the presence of SOD-PEG (100 U/mL).
Statistical analysis
The results are presented as mean ± S.E.M. Statistical analysis of the results was performed by using the one-way analysis of variance (ANOVA) and Tukey's post hoc test, when more than two groups were compared, and by using the Student's t test for comparison between two groups. Results were considered statistically significant for P < 0.05. The GraphPad Prism 5 software (Graph Pad Software, Inc., San Diego, CA, USA) was used.
Results
The cytotoxic effect of palmitic acid was evaluated in cultured cells treated with 25 µM palmitic acid (concentration used in all assays) for 3 h. At this concentration of palmitic acid no loss of plasma membrane integrity was observed. The percentage of viable cells in the control group and in the group treated with palmitic acid was the same (96% for both groups) (Fig. 1) .
NO production was assessed by measurement of nitrite and by intracellular DAF-2-DA fluorescence. As indicated in the two methods used, palmitic acid elevated NO production in skeletal muscle cells ( Fig. 2A and 2B ). The efficiency of the measurement of nitric oxide production by using the fluorescent compound DAF-2-DA was tested in the presence of a mixture of LNA and L-NAME (NOS inhibitors) at 500 µM, to ensure the inhibition of all three (Fig. 2B) . The samples containing this mixture presented a significant decrease in NO production confirming the specificity of the method used to detect this RNS.
To evaluate the participation of superoxide on nitric oxide production, cells were incubated with DAF-2-DA (10 µM) for 1 h in the presence or absence of palmitic acid (25 µM), a superoxide generator system (X-XO), a mixture of NOS inhibitors (LNA / L-NAME) at 500 µM and SOD-PEG (100 U/mL). Firstly, a control assay was carried out to demonstrate the effect of palmitic acid (25 µM) on ROS production, and also to test the specificity of the X-XO system. Both treatments induced a significant increase of ROS production by 1.45-and 1.9-fold, respectively (Fig. 3) . After this control assay, the effect of the increase of superoxide content, induced by palmitic acid and X-XO system, on NO production was evaluated. Palmitic acid and X-XO system increased NO production (by 1.93-and 3.33-fold, respectively). These effects were abolished in cells treated with NOS inhibitors or SOD-PEG (Fig. 4) . 
Cellular Physiology and Biochemistry
The influence of palmitic acid on NOS expression was then evaluated. The treatment with this fatty acid at 25 µM induced a marked increase (1.6-fold) on iNOS expression only when compared with control, as measured by western blotting analysis (Fig. 5) . nNOS and eNOS showed no changes with palmitic acid treatment (1.825±0.269 and 1.606±0.372, respectively) when compared to control group (1.905±0.444). NF-κB activation by palmitic (Fig. 6) . In order to investigate the participation of ROS in NF-κB activation by palmitic acid in skeletal muscle cells, the antioxidant enzyme SOD-PEG was added to the culture medium. The activation of NF-κB induced by palmitic acid was abolished by SOD-PEG treatment (Fig. 7) . 
Discussion
The treatment of skeletal muscle cells with palmitic acid at 25 µM increased NO production through superoxide generation, and involved increased iNOS expression, and NF-κB activation.
The concentration of palmitic acid used in the present study (25 µM) was chosen due to the fact that FFA are highly bound to albumin in plasma, and the unbound fraction is extremely low [35, 36] . According to Steinberg [37] , about 99.5% of the total FFA are bound to albumin in plasma, being only 0.5% free. Taking into account that total plasma FFA concentration can exceptionally reach 5 mM in some pathological conditions [38] , the unbound fraction can reach up to 25 µM. According to our previous study [16] , the concentration of unbound to albumin FFA is about 8.4 µM when the total plasma FFA concentration (bound and unbound) is 270 µM. Then, it is possible that, under physiological conditions, such as fasting and prolonged exercise or in common disorders (such as obesity and diabetes), when plasma FFA concentration reaches up to 800 µM, the unbound fraction of FFA is near 25 µM.
Rachek et al. [21] showed that palmitic acid under certain circumstances can be toxic to skeletal muscle cells. This process involves mitochondrial oxidative stress leading to impaired contraction activity of skeletal muscle and cell death [39] . In the present study, the cells were incubated for 3 h with 25 µM palmitic acid and no signs of cytotoxicity were observed. So, the concentration of 25 µM palmitic acid was not toxic to skeletal muscle cells. This concentration of palmitic acid was also used in our previous study to evaluate the effect of this fatty acid on superoxide production by skeletal muscle cells [20] .
The effect of 25 µM palmitic acid on nitric oxide production by skeletal muscle cells was then investigated. In both methods used, a significant increase of NO production by skeletal muscle cells incubated with palmitic acid was found. Taking into account that palmitic acid increases both NO and superoxide production [20] , a possible relationship between the productions of these two reactive species was then evaluated. Cells treated with palmitic acid and X-XO system showed a marked increase of NO production, which was abolished in the presence of SOD-PEG. These findings indicate that NO production is stimulated by superoxide generation in skeletal muscle cells. According to McCann et al. [9] , the inducible isoform of NOS (iNOS) does not significantly contribute for the basal production of NO by skeletal muscle. However, once stimulated, NO production can increase up to 1,000 times. Taking this information into account, the expression of iNOS protein in skeletal muscle cells incubated with palmitic acid was evaluated. Interestingly, even after only 1 h of treatment, an increase in expression of this enzyme was observed. An opposite response was obtained when the cells were treated with SOD-PEG. Again, a key role of superoxide in the control of NO production by skeletal muscle cells was observed. Probably, after this short period of time (1 h), superoxide may increases iNOS expression by a post-transcriptional mechanism, such as increase of its mRNA stabilization. This event may occur by the regulation of PKC activity. According to Barbieri et al. [40] and Knapp et al. [41] , superoxide can induce a direct activation of PKC enzyme activity via thiol modification and modulation of zinc content. Additionally, it was already described that PKC is specifically implicated in the enhanced stability of many labile mRNAs, such as those encoding p21, Bcl-2, IL-1 and iNOS [42] . With that, superoxide may induce an increase of iNOS content due to an optimization of its mRNA stability, what can occur in consequence of PKC activation.
Even though that an acute treatment with palmitic acid can lead to an increased amount of iNOS protein, a longer period of cell exposure to this fatty acid may lead to an increase of iNOS content in a higher extent. The expression of iNOS is regulated by NF-κB, and palmitic acid has been described to activate this transcription factor in 3T3-L1 adipocytes, pericytes, L6 myotubes, mouse C2C12 myoblasts, human promonocytic cell line U937, human endothelial cells and mouse macrophage [43] . It has been also described that, when used three different cell types (monocytic cell line U937, Jurkat T lymphocytes, and peripheral blood T cells), NF-κB activation was easily detected after only 2.5-5 min after stimulation [44] . So, NF-κB activation was then investigated under the conditions of this study. NF-κB is a transcription factor composed by members of the Rel family (p50/NF-κB1, p65/RelA, p52/NF-κB2, RelB, c-Rel, p105 and p100) usually found in the cytosol as a heterodimer complex being bound to its inhibitory protein IκB [45] . Superoxide induces IkB phosphorylation through activation of IkB kinase (IKK) and leads to dissociation and translocation of NF-κB active complex (p50/p65) to cell nucleus that binds to a specific sequence of DNA [45] . NF-κB regulates expression of several genes involved in the immune and inflammatory responses and cell survival and adhesion [46] .
An increase of NF-κB activation in cells treated with palmitic acid was observed, however, in the presence of the antioxidant enzyme (SOD-PEG) this activation was reduced reaching control values. Similar results were observed in lymphocytes exposed to palmitic acid [47] . Taking together, these findings suggest that exposing cells to palmitic acid can induce an increase of superoxide production, which lead to an activation of NF-κB, a transcription factor responsible to control iNOS expression, that may induce an augment of NO production.
Actually, palmitic acid can induce NF-κB activation in skeletal muscle cells by two ways: (1) through increased production of superoxide after being metabolized and also (2) by accumulation inside the cells, leading to a direct activation of PKC, which in turn phosphorylates and activates IKK [48] . It is already well described that intracellular accumulation of fatty acids has been shown to be cytotoxic [49, 50] . According to our results both mechanisms can occur in our model once palmitic acid is capable to increase the production of superoxide and NO, which are both toxic to the cells. In addition, NO can react with superoxide to produce peroxynitrite (a more reactive specie), in a much more efficient reaction (3 times faster) than that of superoxide with SOD [7, 9] . Peroxynitrite can nitrate tyrosine residues in a number of proteins [51] and modulates their functions [52] .
In opposition to the adverse effects mentioned above, the acute production of NO, as observed during a physical exercise, has an important metabolic role. NO interacts and inhibits, in a reversible manner, the activity of CcO (cytochrome c oxidase -complex IV), an Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry enzyme of the mitochondrial electron transport chain [53, 54] . CcO catalyses the oxidation of cytochrome c and the reduction of oxygen (O 2 ) to water in order to produce ATP [54] . NO inhibits CcO in a competitive manner with O 2 , leading to a decrease of the affinity of the enzyme for O 2 , and also by increasing the Km of CcO for oxygen, and so modulates mitochondrial respiration [53] . The existence of an isoform of NOS associated to the mitochondrial inner membrane (mtNOS), recently described, can also facilitate the inhibition of CcO [55, 56] . The meaning for the control of NO production by palmitic acid is postulated in the Figure 8 . An acute augment of NO production induced by palmitic acid in skeletal muscle cells, during physical exercise, facilitates the O 2 distribution in skeletal muscle being particularly important in conditions of low O 2 concentration [53] . However, a long time exposure to palmitic acid, that occurs in some specific conditions such as ethanol abuse, cold stress, sepsis, cachexia, diabetes and aging [38, 57, 58] , may induce a high production of peroxynitrite, and consequently higher oxidative damage to skeletal muscle cells causing loss of muscle mass and weakness.
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